RecruitingNot ApplicableNCT07373353

A Clinical Evaluation of AMJ-401

AMJ-401 Japan Clinical Trial

Sponsor

Abbott Medical Devices

Enrollment

50 participants

Start Date

Dec 17, 2025

Study Type

INTERVENTIONAL

Conditions

Ischemic Heart Disease (IHD)

Summary

A Clinical Evaluation of AMJ-401 in the Treatment of Subjects with Ischemic Heart Disease in Japan

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called AMJ-401 for people with ischemic heart disease (ihd). The study is currently recruiting participants at 10 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAMJ-401

Patients undergoing percutaneous coronary intervention of one or two de novo native coronary artery lesions with AMJ-401 in separate epicardial coronary vessels